These 5 Healthcare Penny Stocks Are Poised To Jump

3. Vical Incorporated (NASDAQ:VICL)

Investors with Long Positions (as of June 30): 8

Aggregate Value of Investors’ Holdings (as of June 30): $9.43 Million

Vical Incorporated (NASDAQ:VICL)’s stock was soaring high in June when a couple of analysts issued a ‘Buy’ rating on the company, However, shares tumbled in the same month after disappointing results for the Phase 1/2 clinical study of the company’s genital herpes vaccine, which also resulted in many hedgies rolling back their stakes in the company. While the total number of hedge funds with holdings in the company fell by one, their total investments shrank by $6.11 million during the second quarter. The aggregate hedge fund holdings at the end of June amassed about 14.7% of Vical’s shares. Ariel Investments, which is managed by John W. Rogers is the largest stockholder of Vical Incorporated (NASDAQ:VICL) within our database and it raised its stake by 8% during the June trimester to 7.46 million shares valued at $5.22 million.